NAVICA Mobile App and BinaxNOW COVID-19 Ag Card
The revolutionary NAVICA™ app helps people navigate daily life in a new normal. NAVICA displays results from the 15-minute BinaxNOW™ COVID-19 Ag Card, a rapid antigen test, to help individuals make informed decisions.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Good results you can count on. Easy to use.
Waived Nasal Swabs.
Good test. Easy to use even for nurses and MA's. Accurate results for the covid 19.
Review Date: 21 Nov 2022 | Abbott
Easy and fast
Covid test
Easy to use, package insert instructions clear and easy to follow. Results are corelate well with PCR . Disposal is safe and the 15 minute wait for results is ideal.
Review Date: 19 Nov 2021 | Abbott
Very efficient.
Medical
Very quick and efficient. The small unit is easy to distribute and very affordable. This made testing our employees much easier during high peaks of COVID.
Review Date: 15 Jun 2021 | Abbott
This product has proved to be a great asset in the fight against covid-19.
Rapid testing for the presence of the covid-19 antigen
Product is easy to use, package insert instructions clear and easy to follow. Results are clear and corelate well with PCR results. Disposal is safe and the 15 minute wait for results is ideal.
Review Date: 15 Jun 2021 | Abbott
The BinaxNOW test can be displayed on our new optional app , Android or Iphone.
IT
With a swab and a card, reliable coronavirus test results in 15 minutes.
Review Date: 2 Feb 2021 | Abbott
Quick and easy to use.
Screening for COVID-19
We only screen individuals who are asymptomatic, not in quarantine/isolation or otherwise suspected of having COVID-19. So far, we have only had negative test results. Several of the patients have been (PCR) tested elsewhere and those results do agree with the rapid test on campus. It seems to be a reliable test.
Review Date: 6 Jan 2021 | Abbott
Winning strategy for getting the COVID pandemic under control.
Detect the presence of Covid-19 antigen
The easiest to use, fastest, most accurate, cheapest, point of care antigen assay on the market.
Review Date: 10 Nov 2020 | Abbott
The revolutionary NAVICA™ app helps people navigate daily life in a new normal. NAVICA displays results from the 15-minute BinaxNOW™ COVID-19 Ag Card, a rapid antigen test, to help individuals make informed decisions.
This first-of-its-kind app, available at no-charge, allows people who test negative to get an encrypted temporary digital NAVICA Pass, similar to an airline boarding pass. NAVICA-enabled organizations will be able to verify an individual’s negative COVID-19 test results by scanning the individual’s digital NAVICA Pass to facilitate entry into facilities, along with hand-washing, social distancing, enhanced cleaning, and mask-wearing.
The BinaxNOW™ COVID-19 Ag Card test has received U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA).*
Only available in the US.
THE NAVICA-BINAXNOW TESTING PROCESS IS SIMPLE:
Scan the participant’s NAVICA ID on their mobile device and verify photo ID match.
Scan the unique QR code on the BinaxNOW COVID-19 Ag Card test to create a secure link between the participant and the test card.
Perform the BinaxNOW COVID-19 Ag Card test, following the package insert instructions.
Rescan the QR code on the test card to confirm the link and chain of custody between the BinaxNOW COVID-19 Ag Card test and the participant.
Visually interpret the test result on the card and submit the positive or negative result accordingly via the NAVICA app.
BINAXNOW COVID-19 Ag CARD
A BREAKTHROUGH ANTIGEN TEST
- Simple test procedure using a direct nasal swab
- Direct nasal swabs from individuals suspected of COVID-19 by their healthcare provider within the first seven days of symptom onset.**
- Onboard extraction allows the swab to be directly inserted into the test card
- Cost-effective, high performing test designed for decentralized testing
- Room temperature storage
- Visually read results in 15 minutes - no instrument required
- Emergency Use Authorization (EUA) supports testing in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation
